The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2023 | Lucchese Joseph | EVP & CFO | Grant(A) | 35K | — | $0 |
| Aug 20, 2023 | Mendelsohn Alan | EVP & CMO | Grant(A) | 35K | — | $0 |
| Aug 20, 2023 | Koconis John | CEO & Chairman | Grant(A) | 70K | — | $0 |
| Apr 15, 2023 | Lucchese Joseph | EVP & CFO | Grant(A) | 23K | — | $0 |
| Apr 15, 2023 | Cohen David E | Director | Grant(A) | 4K | — | $0 |
| Apr 15, 2023 | Cohen David E | Director | Grant(A) | 4K | — | $0 |
| Apr 15, 2023 | Sitar Edward J | Director | Grant(A) | 5K | — | $0 |
| Apr 15, 2023 | Sitar Edward J | Director | Grant(A) | 5K | — | $0 |
| Apr 15, 2023 | Pirozzi Gianluca | Director | Grant(A) | 4K | — | $0 |
| Apr 15, 2023 | Pirozzi Gianluca | Director | Grant(A) | 4K | — | $0 |
| Apr 15, 2023 | Mendelsohn Alan | EVP & CMO | Grant(A) | 23K | — | $0 |
| Apr 15, 2023 | Gaal Lubor | Director | Grant(A) | 4K | — | $0 |
| Apr 15, 2023 | Gaal Lubor | Director | Grant(A) | 4K | — | $0 |
| Apr 15, 2023 | Koconis John | CEO & Chairman | Grant(A) | 45K | — | $0 |
| Dec 15, 2022 | Sitar Edward J | Director | Grant(A) | 3K | $1.63 | $4K |
| Apr 15, 2022 | Gaal Lubor | Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2022 | Gaal Lubor | Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2022 | Pirozzi Gianluca | Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2022 | Pirozzi Gianluca | Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2022 | Sitar Edward J | Director | Grant(A) | 150K | — | $0 |
| Apr 15, 2022 | Sitar Edward J | Director | Grant(A) | 150K | — | $0 |
| Apr 15, 2022 | Cohen David E | Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2022 | Cohen David E | Director | Grant(A) | 100K | — | $0 |
| Apr 15, 2022 | Koconis John | CEO & Chairman of the Board, Director | Grant(A) | 600K | — | $0 |
| Apr 15, 2022 | Mendelsohn Alan | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Apr 15, 2022 | Lucchese Joseph | CFO,EVP,Secretary&Treasurer | Grant(A) | 300K | — | $0 |
| Mar 4, 2022 | Rome Zachary | Director | Option exercise(M) | 79K | $0.01 | $793 |
| Mar 4, 2022 | Rome Zachary | Director | Tax withholding(F) | 20K | $0.28 | $5K |
| Mar 4, 2022 | Rome Zachary | Director | Option exercise(M) | 79K | — | $0 |
| Mar 4, 2022 | Rome Zachary | Director | Disposed to issuer(D) | 53K | — | $0 |
| Dec 15, 2021 | Koconis John | CEO & President, Director | Buy(P) | 20K | $0.38 | $8K |
| Nov 23, 2021 | Sitar Edward J | Director | Buy(P) | 15K | $0.46 | $7K |
| Nov 23, 2021 | Mendelsohn Alan | Chief Medical Officer | Buy(P) | 10K | $0.47 | $5K |
| Sep 27, 2021 | Lucchese Joseph | CFO, Executive VP & Treasurer | Grant(A) | 361K | — | $0 |
| Sep 14, 2021 | Koconis John | CEO & President, Director | Grant(A) | 890K | — | $0 |
| Sep 14, 2021 | Rome Zachary | COO, Executive VP & Secretary, Director | Grant(A) | 561K | — | $0 |
| Sep 2, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 225K | $0.94 | $212K |
| Sep 1, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 151K | $0.92 | $138K |
| Aug 31, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 150K | $0.91 | $137K |
| Aug 30, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 100K | $0.93 | $93K |
| Aug 26, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 100K | $0.92 | $92K |
| Aug 25, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 100K | $0.91 | $91K |
| Aug 24, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 100K | $0.93 | $93K |
| Aug 20, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 50K | $0.91 | $46K |
| Aug 19, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 50K | $0.95 | $48K |
| Aug 18, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 75K | $1.00 | $75K |
| Jul 1, 2021 | Cohen David E | Director | Grant(A) | 72K | — | $0 |
| Jul 1, 2021 | Gaal Lubor | Director | Grant(A) | 72K | — | $0 |
| Jul 1, 2021 | Mendelsohn Alan | Chief Medical Officer | Grant(A) | 348K | — | $0 |
| Jul 1, 2021 | Pirozzi Gianluca | Director | Grant(A) | 48K | — | $0 |
| Jul 1, 2021 | Sitar Edward J | Director | Grant(A) | 48K | — | $0 |
| Jun 15, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 28K | $1.26 | $36K |
| Jun 14, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 146K | $1.27 | $186K |
| Jun 10, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 185K | $1.26 | $233K |
| Jun 9, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 96K | $1.27 | $123K |
| Jun 8, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 306K | $1.29 | $394K |
| Jun 2, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 10K | $1.26 | $12K |
| Jun 1, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 9K | $1.26 | $11K |
| May 28, 2021 | TardiMed Sciences LLC | 10% Owner | Sell(S) | 48K | $1.27 | $61K |
| Mar 3, 2021 | Mendelsohn Alan | Chief Medical Officer | Buy(P) | 2K | $2.17 | $4K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).